1) HBeAg negative
HBeAg阴性
1.
The preliminary observation of adefovir treatment for 46 patients with HBeAg negative chronic hepatitis B;
阿德福韦治疗HBeAg阴性慢性乙型肝炎患者的初步观察
2.
Study on relationgship between viral dynamics change and curative effect in patients with HBeAg negative chronic hepatitis B treated with adefovir
阿德福韦治疗HBeAg阴性慢性乙型肝炎患者病毒动力学变化与疗效关系的研究
3.
Study on clinical and pathological characteristic in HBeAg negative chronic hepatitis B patients with nonalcoholic fatty liver disease
HBeAg阴性慢性乙型肝炎并非酒精性脂肪性肝病56例临床及病理特征
2) HBeAg-negative
HBeAg阴性
1.
Research Progress of HBeAg-negative Chronic Hepatitis B
HBeAg阴性慢性乙型肝炎研究进展
2.
To investigate the effect ofα-interferon (INF-α)therapy for HBeAg-negative chronic hepatitis B (CHB).
了解干扰素治疗HBeAg阴性慢性乙型肝炎的疗效。
3.
Objective To probe into the clinical characteristic of the HBeAg-negative chronical hepatitis-B(e-CHB for short)and its relationships with the G1896A mutation in the precore and with the A1762T/G1764A twin-mutation in the basal core promoter(BCP for short).
目的探讨HBeAg阴性慢性乙型肝炎(以下简称e-CHB)的临床特点及与前C区G1896A变异及基本核心启动子(BCP)区A1762T/G1764A双变异的关系。
3) negative HBeAg
HBeAg阴性
1.
The long-term clinical efficacy of lamivudine in treatment of chronic hepatitis B with negative HBeAg;
拉米夫定治疗HBeAg阴性的慢性乙型肝炎的长期疗效
4) HBeAg-negative chronic hepatic disease
HBeAg阴性慢性肝病
1.
Detection of HBV DNA in serum and peripheral blood mononuclear cells in patients with HBeAg-negative chronic hepatic disease;
HBeAg阴性慢性肝病患者血清中和外周血单个核细胞内HBV DNA的检测
5) HBeAg-negative chronic hepatitis B
HBeAg阴性慢性乙肝
1.
Objective To explore the significance of hepatitis B virus large surface protein(LHBs) in the diagnosis of viral repication in patients with HBeAg-negative chronic hepatitis B.
结果1在807例HBeAg阴性慢性乙肝血清中HBV DNA阳性率为54。
6) the chronic hepatitis B With negative HBeAg
HBeAg阴性慢性肝炎
1.
To research the effect of Qiang-gan decoction and lamivudine in treating the chronic hepatitis B With negative HBeAg .
选择HBeAg阴性慢性肝炎患者135例,随机分为3组,分别用中药强肝汤、西药拉米夫定以及强肝汤与拉米夫定联合治疗,观察3组在治疗前后HBV-DNA和ALT的变化;主要自觉症状(乏力、纳差、腹胀和肝区不适)的变化;治疗48周YMDD出现的情况以及在停药后24周3组持续应答情况。
补充资料：HBeAg
分子式：
CAS号：
性质：系由病毒基因C基因编码的，由第一个ATG起始的产物，叫前核心蛋白。切除pre C序列和精氨酸丰富的C末端后即成e抗原。分泌至血液中。
CAS号：
性质：系由病毒基因C基因编码的，由第一个ATG起始的产物，叫前核心蛋白。切除pre C序列和精氨酸丰富的C末端后即成e抗原。分泌至血液中。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条